Lakestar is a venture capital firm investing in technology companies led by exceptional entrepreneurs. Early investments included Skype, Spotify, Facebook, and Airbnb. Since raising the first fund in 2013, Lakestar manages an aggregated volume of over EUR 1bn across three early-stage funds, and more recently a growth fund.  The company has expanded and broadened its portfolio and holds investments in the likes of Opendoor, Oscar, GetYourGuide, Glovo, Sender, Eigen, Five, Revolut, and Hometogo to name a few. Lakestar has a presence in Berlin, Zurich, and London. Lakestar helps companies to identify new markets and expand into them rapidly, with a focus on the US and Europe. The team advises and supports portfolio companies in business development, recruitment, technology, and marketing. The investments range from early-stage companies to those in their growth stage.

Lakestar

Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies. The firm invests across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country.

Flare Capital Partners

Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology. It is dedicated to working side-by-side with visionary entrepreneurs who want to transform care delivery and health outcomes for the most underserved and higher need populations across the country. Town Hall seeks to invest in and support the best entrepreneurs - those bold enough to want to change the system and impact millions of lives.

Town Hall Ventures

New Enterprise Associates is a global venture capital firm that focuses on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from the seed stage through the IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

New Enterprise Associates

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, and cardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Amgen Ventures

Oxeon is an executive search and venture firm partnering with impactful growth stage healthcare businesses to solve our nation’s most complex challenges. We connect our healthcare company partners with the fundamental drivers of business growth: great people, transformational business development partnerships, strategic investments, next generation business ideas, as well as various advisory and other growth-related services. Oxeon's foundation is built on our deep relationships with leading companies and executives in healthcare IT and services. Through these relationships, we: - find the right leaders to drive business growth for our clients - connect companies across our network to build business - translate insights about unmet industry needs into new companies or products - invest at every step to ensure our interests are aligned with our clients and partners

Oxeon Partners

UCB focuses on research and development of medications centered on epilepsy, parkinson's disease, and crohn's disease. Their research and development activities in neurology, immunology, and other areas.

Union Chimique Belge

Sanofi offers research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme.

Sanofi

Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.

Sanofi Ventures

Horizon Healthcare Services offers patients and their families the special coordinated care they need in the comfort and security of the home environment.  - Range of flexible, customized treatment therapies, from single therapies such as IV antibiotic therapy, to highly complex therapies - 24-hour intake and free insurance verification prior to service - Consistently high patient satisfaction - Experienced pharmacists - Accreditation by the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO)

Horizon Healthcare Services

McKesson Ventures they help entrepreneurs in healthcare technology and services to create efficient health care delivery systems for key stakeholders on all sides of the health care economy.

McKesson Ventures

Investing since 1991, EDBI is a Singapore-based global investor in select high-growth technology sectors ranging from Information and Communication Technology (ICT), Emerging Technology (ET), Healthcare (HC), and other strategic industries. As a value-creating investor, EDBI assists companies to achieve their ambitious goals by leveraging their broad network, resources, and expertise. With their patient capital, EDBI supports companies seeking to grow in Asia and globally through Singapore.

EDBI

Greenspring Associates is a global investment firm that provides commingled funds and customized partnership capabilities to a diverse group of institutions and individuals in North America, Europe, Asia, the Middle East, and Australia. Through a synergistic platform, the firm invests in established and emerging venture capital fund managers, in early and growth stage venture-backed companies and in secondary venture capital fund and secondary direct investments. Currently managing over $7.3 billion of committed capital, its dedicated investment team combines broad venture fund and direct investment expertise.

Greenspring Associates

Johnson & Johnson Innovation accelerates early-stage innovation through strategic collaboration. It connects potential collaborators to resources with the goal of assisting them in advancing transformation science and technology across the pharmaceutical, medical device, and consumer healthcare spectrums.

Johnson & Johnson Innovation – JJDC

Warburg Pincus LLC is a leading global private equity firm focused on growth investing. The firm has more than $60 billion in private equity assets under management. The firm’s active portfolio of more than 200 companies is highly diversified by stage, sector, and geography. Warburg Pincus is an experienced partner to management teams seeking to build durable companies with sustainable value. Founded in 1966, Warburg Pincus has raised 19 private equity funds, which have invested more than $90 billion in over 930 companies in more than 40 countries.  The firm is headquartered in New York with offices in Amsterdam, Beijing, Berlin, Hong Kong, Houston, London, Luxembourg, Mumbai, Mauritius, San Francisco, São Paulo, Shanghai, and Singapore. For more information please visit www.warburgpincus.com.

Warburg Pincus

Foresite Capital is a healthcare and life sciences investment firm. They take a data-driven approach to invest in startups that employ biology and big data to improve healthcare, such as 10x Genomics, Relay Therapeutics, Element Biosciences, and Inscripta.

Foresite Capital

B Capital Group backs brash entrepreneurs building technology companies. With offices in Los Angeles, San Francisco, and Singapore, B Capital Group focuses on pioneering start-ups that are ready to scale across the global stage. Partnering with Boston Consulting Group, and its incubation arm BCG Digital Ventures, B Capital delivers access to top corporations to match start-ups with the world's most powerful CEOs, platforms, and brands. B Capital Group's unique multinational presence, combined with deep industry expertise, has built a portfolio of B2B and B2B2C startups that are transforming large traditional industries across borders and geographies. It helps startups navigate business challenges, raise capital, and attract talented leadership at key points of their journeys to scale.

B Capital

Aetion

Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers. With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care.  Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson & Johnson Innovation — JJDC, Inc., UCB, and Horizon Health Services, Inc.

<div>  <p>    Aetion delivers real-world evidence (RWE) and outcomes-based analytics solutions to life sciences companies, payers, and at-risk providers.  </p>  <p>    With its patented rapid-cycle analytics technology, the Aetion Evidence Platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in inpatient care.  </p>  <p>    Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, Greenspring Associates, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Amgen Ventures, Johnson &amp; Johnson Innovation &mdash; JJDC, Inc., UCB, and Horizon Health Services, Inc.  </p></div>

Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer

The toolkit to build machine learning applications at scale

Machine Learning Infrastructure

Platforms and frameworks that help developers build and train ML models.

Platforms that deploy and host the trained and tested models in production and integrate them into applications through APIs.

Platforms that generate artificial data that mimics the characteristics of real data, which is then used to train ML models at scale.

Platforms that help monitor and manage ML models in training and deployment to track performance, conduct variance analysis, and optimize performance.

Makers of hardware such as CPUs, GPUs, and other application-specific hardware required to train and run ML workloads.

Integrated solutions that handle the end-to-end processes of developing, training, deploying, and monitoring ML models.

Data exchange providers and platforms that offer data labeling services via manual and/or software methods, which are used as input to train ML models.

Aetion

Featured Industries

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless